Trials / Completed
CompletedNCT06542172
Impact of Low-fat and Full-fat Milk on Lipids and Cardiac Function in Patients With Coronary Artery Disease
Impact of Low-fat and Full-fat Milk on Lipids and Cardiac Function in Patients With Coronary Artery Disease: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This trial aimed to investigate the effects of low-fat and full-fat milk on patients with coronary artery disease (CAD).
Detailed description
The effects of low-fat and full-fat milk on lipid profiles and sphingolipid profiles in CAD patients are not well understood. In addition, milk intake is at a low level in the Chinese population compared with developed countries. Therefore, we aimed to conduct a randomized controlled trial to investigate the effects of low-fat and full-fat milk on lipid profiles, sphingolipid profiles, and cardiac performance in Chinese CAD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 500 mL/day of full-fat milk from corn-fed cows (fat >3.8%) for 12 weeks | All milk is provided by the Inner Mongolia Yili Industrial Group Limited by Share Ltd (Inner Mongolia, China). |
| DIETARY_SUPPLEMENT | 500 mL/day of full-fat milk from grass-fed cows (fat >3.8%) for 12 weeks | All milk is provided by the Inner Mongolia Yili Industrial Group Limited by Share Ltd (Inner Mongolia, China). |
| DIETARY_SUPPLEMENT | 500 mL/day of low-fat milk (fat <1.5%) for 12 weeks | All milk is provided by the Inner Mongolia Yili Industrial Group Limited by Share Ltd (Inner Mongolia, China). |
Timeline
- Start date
- 2020-09-03
- Primary completion
- 2021-03-04
- Completion
- 2021-03-04
- First posted
- 2024-08-07
- Last updated
- 2024-08-07
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06542172. Inclusion in this directory is not an endorsement.